GPX4 and hepatocellular carcinoma: NeuroD1 promotes resistance to ferroptosis in hepatocellular carcinoma (HCC) by upregulating GPX4, enhancing cell survival and tumorigenic potential, highlighting it as a potential target for antitumor therapy.